Delivery Order SPE2DB22D2211-SPE2DB24FPFQ2

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,200.38 firm-fixed-price contract is for the delivery of RISPERDAL 0.5 MG TABLET 60S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency awarded a $612 delivery order to Amerisourcebergen Drug Corporation for Risperdal Consta 37.5 mg vials. The firm fixed price order is being fulfilled under an existing Prime Vendor Pharmaceutical contract vehicle and will provide the specified pharmaceutical products to DLA from Amerisourcebergen's facility in Conshohocken, Pennsylvania. Performance is required from July 24-25, 2023, with no set aside designation or involvement of major subcontractors according to...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,275.72 firm-fixed-price contract is for the delivery of Risperdal 3 mg tablets, a mental health medication, with an ultimate completion date of October 24, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,072.55 for the supply of Risperdal 1 mg tablets. The contract was awarded on April 21, 2022, by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for delivering the pharmaceutical product to support military...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Risperdal 1 mg tablets, a mental health medication, for $1,023.97. The contract has a period of performance ending on June 30, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,508.01 firm fixed-price delivery order is for the supply of 500 tablets of 0.25 mg risperidone, a medication used to treat mental health conditions. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,130.27, for the delivery of Risperidone 2 mg tablets. The contract has a completion date of June 12, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Risperdal 2 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price, $10,348.17 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Risperidone 2 mg tablets. The contract has a ceiling value of $1,984.46 and a period of performance through June 5, 2025. It is a firm-fixed-price contract, without any set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM) and has a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Risperidone 0.5 mg tablets in 500-count bottles. The $1,276.62 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPFQ2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,617.24 firm fixed price contract is for the supply of Risperdal Consta 25 mg vials, a specialty medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by August 28, 2024. Amerisourcebergen's extensive federal contracting experience and robust supply chain capabilities enable it to efficiently deliver critical medical commodities to various government agencies and healthcare programs.

Generated 11/26/24, 9:15 AM